2001
DOI: 10.1016/s0041-1345(00)02467-2
|View full text |Cite
|
Sign up to set email alerts
|

C4d deposits in renal allografts are associated with inferior graft outcome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
23
0
1

Year Published

2003
2003
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(28 citation statements)
references
References 4 publications
4
23
0
1
Order By: Relevance
“…Regarding C3d-positive biopsies as a different expression of what is now generally excepted as the "C4d-positive type of rejection" (3,6,8,9,(13)(14)(15) implicates the risk of oversimplification. However, to separate both entities, a direct comparison between C3dϩ C4dϪ patients on the one hand and C3dϪ C4dϩ patients and C3dϩC4dϩ recipients on the other hand could indicate whether alternative pathway activation carries a distinct risk.…”
Section: Immunohistochemistrymentioning
confidence: 99%
See 2 more Smart Citations
“…Regarding C3d-positive biopsies as a different expression of what is now generally excepted as the "C4d-positive type of rejection" (3,6,8,9,(13)(14)(15) implicates the risk of oversimplification. However, to separate both entities, a direct comparison between C3dϩ C4dϪ patients on the one hand and C3dϪ C4dϩ patients and C3dϩC4dϩ recipients on the other hand could indicate whether alternative pathway activation carries a distinct risk.…”
Section: Immunohistochemistrymentioning
confidence: 99%
“…Donor-specific anti-human leukocyte antigen (HLA) type I and II antibodies are implicated in the pathogenesis of this type of rejection (6); however, some investigators have not found a clear relationship between HLA antibodies and acute humoral rejection (7). Patients developing this type of C4d-positive acute rejection (AR) are at high immunologic risk (8) and are more likely to lose their graft (4,5,7,9). Recently, it was shown that the presence of peritubular C4d deposition was a predictor of graft survival independent of the histologic type of AR and classic clinical prognostic factors (8).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Over the last decade it has been demonstrated that some of the DSAs detected with SA SP analysis but not with CDC (FC pos/ CDC neg) can activate the complement system [124][125][126][127][128] .…”
Section: Component 1q Sa Sp Binding Assaymentioning
confidence: 99%
“…Five renal biopsies negative for HCMV DNA by ISH were also included as negative controls. All renal biopsies were tested for the presence of antibody (Ab)-mediated rejection using a polyclonal peptide-specific anti-C4d antibody (C4dpAb; Biomedica, Vienna, Austria) [Bohmig et al, 2001]. Normal rabbit IgG serum (Sigma) diluted to the same concentration as the anti-C4d Ab was used as a negative control.…”
Section: Immunohistochemistrymentioning
confidence: 99%